- Perspectives
- Thomas A. Ban: A brief historical exchange between Larry Stein and Joseph Knoll.
- Thomas A. Ban: In historical perspective. Peralta, Cuesta and their Associates findings on the highest familiality of Leonhard’s classification in polynosologic study.
- Thomas A. Ban: The Ewen Cameron Story..
- Thomas A. Ban: The RDoC in historical perspective.
- Barry Blackwell’s comment on de Leon J, Wise TN, Balon R, Fava G: Dealing with Difficult Medical Colleagues published in Psychotherapy and Psychosomatics
- Barry Blackwell: Risk and relevance to lithium usage.
- Barry Blackwell’s comment (Harvey V. Fineberg: Conflict of Interest: Why Does It Matter? Viewpoint. JAMA 2017; 317: 8)
- W. Edwin Fann A History of The Tennessee Neuropsychiatric Institute
- Thomas A. Ban’s comment Central theme of clinical research at the TNI from the mid-1970s to the 1980s
- Barry Blackwell’s comment on Thomas A. Ban‘s comment titled “Central theme of clinical research at the TNI from the mid-1970s to the 1980s”
- Thomas A. Ban’s reply to Barry Blackwell’s comment
- Aitor Castillo’s comment on Barry Blackwell’s comment on Thomas Ban’s comment
- Samuel Gershon's comment on Barry Blackwell's comment on Thomas A. Bans comment.
- Barry Blackwell’s comment to Aitor Castillo’s and Sam Gershon’s comments on comment on Thomas A. Ban’s comment
- Samuel Gershon’s response to Barry Blackwell’s reply to his comment on Blackwell’s comment on Thomas Ban’s comment, The Central Theme of the Clinical Division
- David Janowsky’s comment on Thomas A. Ban's comment
- William Petrie’s comment on Thomas A. Ban’s comment
- Thomas A. Ban’s comment. CODE System – Historical Development
- Thomas A. Ban’s comment. My years at the TNI and Vanderbilt. Leo E. Hollister’s interview of Thomas A. Ban
- Thomas A. Ban’s comment. The TNI story: How I saw it
- Aitor Castillo’s comment. My TNI experience
- David S. Janowsky’s comment My time at the Tennessee Neuropsychiatric Institute (1970 – 1973)
- W. Edwin Fann’s reply to David Janowsky’s comments
- Rudra Prakash’s comment. Reflections of and tribute from a trainee
- Fridolin Sulser (1926 –2016) on the Tennessee Neuropsychiatric Institute
- Fridolin Sulser’s comment. My years at the TNI and Vanderbilt. David Healy’s interview of Fridolin Sulser
- Edwin Fann’s comment on Fridolin Sulser (1926 – 2016) on the Tennessee Neuropsychiatric Institute
- Samuel Gershon’s comment on collating document
- Samuel Gershon’s comments on Ronald Pies’ “Do antipsychotics thin the brain?” Journal of Clinical Psychopharmacology 2018; 38 (3): 167- 9.
- Samuel Gershon’s comment on Plinio C. Casarotto et al.’s Antidepressant drugs act by directly binding to TRKB neurotrophin receptors..
- Samuel Gershon’s comment on Herwig Czech, Gabor S. Ungvari, Kamila Uzarczyk, Paul Wydlow and Gabor Gazdag’s paper on ECT in the shadow of the gas chamber and Gabor Gazdag, Gabor S. Ungvari and Herwig Czech’s paper on Mass killing under the guise of ECT.
- Laszlo Gyermek: The role of the tropane skeleton in drug research
- Carlos Hojaij’s Comment on Carlos Morra’s “The Mental Status Examination and General Psychopathology, Volume 1, Sensory-perception.”
- Carlos R. Hojaij: Ethics for psychiatrists.
- Gerd Huber and Gisela Gross: The Development of the Psychopathology in Germany in the Last Decades [20th century] with an Introduction by Carlos R. Hojaij.
- Martin M. Katz’s comment on Jose de Leon’s article “Focusing on drug versus disease mechanisms and on clinical subtyping to advance personalized medicine”
- Carl Lange: On periodical depressions and their pathogenesis Speech delivered to the ‘Medical Society of Copenhagen', 19 January 1886.
- Alex Last: BBC Witness History. The First Antipsychotic Drug. An interview of Thomas Ban..
- Carlos Morra: Argentina’s controversial National Law of Mental Health No. 26, 657..
- Carlos Morra: The use of human-induced pluripotent stem cells (iPSC) in schizophrenia. Will this technology generate a leap forward in the disease´s modeling?
- Review of the modern gene editing techniques: CRISPR-Cas applications in iPSC-derived cultures (Carlos Morra: Biomarkers to replace clinical endpoints for the generation of diagnostic hypotheses with the potential to guide the development of novel psychot
- János Radó’s comment on Lin, Zhang, Feng, et al., “Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.”.
- Janos Radó: Mechanism of Lithium Induced Polyuria in Historical Perspective.
- Janusz Rybakowski: Emil Kraepelin's dichotomy of “endogenous psychoses” in historical perspective.
- Mary Seeman’s comment on Jack R. Foucher et al.’s paper on Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: A review of their validity.
- Philip Seeman and Mary V. Seeman: The Dopamine Hypothesis of Schizophrenia in Historical Perspective..
- Edward Shorter’s comment on Herwig Czech, Gabor Ungvari, Kamila Uzarzzyk and Gabor Gazdag’s 2020 paper, “Electroconvulsive therapy in the shadow of the gas chamber. Medical innovations and human experimentation in Auschwitz.”
- Edward Shorter’s comment on Jack R. Foucher et al.’s paper on Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: A review of their validity.
- Hector Warnes’ comment on Despoina Asanaglou et al.’s 2021 paper, “Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors.”
- Hector Warnes’ comment on Silberman, Balon, Starcevic et al “Benzodiazepines: it ́s time to return to the evidence.”
W. Edwin Fann: A History of The Tennessee Neuropsychiatric Institute
CLICK HERE TO OPEN THE DOCUMENT
March 01, 2018